Literature DB >> 8543567

Rat epidermal cathepsin L-like proteinase: purification and some hydrolytic properties toward filaggrin and synthetic substrates.

A Kawada1, K Hara, M Hiruma, H Noguchi, A Ishibashi.   

Abstract

We have purified cathepsin L-like proteinase from rat epidermis, determined its NH2-terminal amino acid sequence, and investigated its proteolytic activities on an intermediate filament-associated protein filaggrin and several synthetic substrates. The amino acid sequence of its NH2-terminus was determined to be Val-Pro-Asn-Ser-Leu-Asp-Trp-Arg-Glu-Lys-Gly-Tyr-Val-Thr-Pro-, which differed from that of rat cathepsin L and was not found in the amino acid sequence data bank. The enzyme consisted of a single-chain form with M(r) 30,000. Its hydrolytic properties toward synthetic substrates were similar to those of cathepsin L in other tissues. The enzyme effectively proteolyzed rat epidermal filaggrin into small fragments at pH 4.0-6.0 and was inhibited by a specific cysteine proteinase inhibitor, N-[N-(L-3-trans-carboxyoxirane-2-carbonyl)L-leucyl]-agmatin. However, cathepsins D and E from rat epidermis did not hydrolyze filaggrin. This study demonstrated that filaggrin was susceptible to degradation by rat epidermal cathepsin L-like proteinase, suggesting that this proteolytic activity may have relevance to skin differentiation, in which acid proteases are thought to participate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543567     DOI: 10.1093/oxfordjournals.jbchem.a124911

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

Review 1.  Revisiting the Roles of Filaggrin in Atopic Dermatitis.

Authors:  Verena Moosbrugger-Martinz; Corinne Leprince; Marie-Claire Méchin; Michel Simon; Stefan Blunder; Robert Gruber; Sandrine Dubrac
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

2.  Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation.

Authors:  Fernando Benavides; Matthew F Starost; Mónica Flores; Irma B Gimenez-Conti; Jean-Louis Guénet; Claudio J Conti
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

3.  Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy.

Authors:  Wendy Potts; Jonathan Bowyer; Huw Jones; David Tucker; Anthony J Freemont; Andrew Millest; Colin Martin; Wendy Vernon; Diane Neerunjun; Gillian Slynn; Fiona Harper; Rose Maciewicz
Journal:  Int J Exp Pathol       Date:  2004-04       Impact factor: 1.925

4.  Immunohistochemical expression of cathepsin L in atopic dermatitis and lichen planus.

Authors:  Zeinab A Ibrahim; Amal A El Ashmawy; Naeim M Abd El-Naby; Hussein M Ghoraba
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

5.  A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis.

Authors:  Aishath S Naeem; Cristina Tommasi; Christian Cole; Stuart J Brown; Yanan Zhu; Benjamin Way; Saffron A G Willis Owen; Miriam Moffatt; William O Cookson; John I Harper; Wei-Li Di; Sara J Brown; Thomas Reinheckel; Ryan F L O'Shaughnessy
Journal:  J Allergy Clin Immunol       Date:  2016-11-29       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.